141 related articles for article (PubMed ID: 18262558)
1. PIK3CA mutation status in Japanese esophageal squamous cell carcinoma.
Mori R; Ishiguro H; Kimura M; Mitsui A; Sasaki H; Tomoda K; Mori Y; Ogawa R; Katada T; Kawano O; Harada K; Fujii Y; Kuwabara Y
J Surg Res; 2008 Apr; 145(2):320-6. PubMed ID: 18262558
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA mutation status in Japanese lung cancer patients.
Kawano O; Sasaki H; Endo K; Suzuki E; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Lung Cancer; 2006 Nov; 54(2):209-15. PubMed ID: 16930767
[TBL] [Abstract][Full Text] [Related]
3.
Liu SY; Chen W; Chughtai EA; Qiao Z; Jiang JT; Li SM; Zhang W; Zhang J
World J Gastroenterol; 2017 Apr; 23(14):2585-2591. PubMed ID: 28465643
[TBL] [Abstract][Full Text] [Related]
4. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
[TBL] [Abstract][Full Text] [Related]
5. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma.
Zheng S; Yang C; Lu M; Liu Q; Liu T; Dai F; Gao X; Sheyhidin I; Lu X
Hum Pathol; 2016 Jul; 53():121-9. PubMed ID: 27001433
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma.
Wang L; Shan L; Zhang S; Ying J; Xue L; Yuan Y; Xie Y; Lu N
PLoS One; 2014; 9(7):e103021. PubMed ID: 25054828
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Shigaki H; Baba Y; Watanabe M; Murata A; Ishimoto T; Iwatsuki M; Iwagami S; Nosho K; Baba H
Clin Cancer Res; 2013 May; 19(9):2451-9. PubMed ID: 23532889
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations.
Bonelli MA; Cavazzoni A; Saccani F; Alfieri RR; Quaini F; La Monica S; Galetti M; Cretella D; Caffarra C; Madeddu D; Frati C; Lagrasta CA; Falco A; Rossetti P; Fumarola C; Tiseo M; Petronini PG; Ardizzoni A
Mol Cancer Ther; 2015 Aug; 14(8):1916-27. PubMed ID: 26013318
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus.
Phillips WA; Russell SE; Ciavarella ML; Choong DY; Montgomery KG; Smith K; Pearson RB; Thomas RJ; Campbell IG
Int J Cancer; 2006 May; 118(10):2644-6. PubMed ID: 16380997
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients.
Ming Z; Jiang D; Hu Q; Li X; Huang J; Xu Y; Liu Y; Xu C; Hua X; Hou Y
Diagn Pathol; 2014 Aug; 9():153. PubMed ID: 25106743
[TBL] [Abstract][Full Text] [Related]
12. Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma.
Hou J; Jiang D; Zhang J; Gavine PR; Xu S; Liu Y; Xu C; Huang J; Tan Y; Wang H; Lu Y; Zheng L; Hou Y; Tan L
Hum Pathol; 2014 Feb; 45(2):352-8. PubMed ID: 24360885
[TBL] [Abstract][Full Text] [Related]
13. Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.
Sawada G; Niida A; Uchi R; Hirata H; Shimamura T; Suzuki Y; Shiraishi Y; Chiba K; Imoto S; Takahashi Y; Iwaya T; Sudo T; Hayashi T; Takai H; Kawasaki Y; Matsukawa T; Eguchi H; Sugimachi K; Tanaka F; Suzuki H; Yamamoto K; Ishii H; Shimizu M; Yamazaki H; Yamazaki M; Tachimori Y; Kajiyama Y; Natsugoe S; Fujita H; Mafune K; Tanaka Y; Kelsell DP; Scott CA; Tsuji S; Yachida S; Shibata T; Sugano S; Doki Y; Akiyama T; Aburatani H; Ogawa S; Miyano S; Mori M; Mimori K
Gastroenterology; 2016 May; 150(5):1171-1182. PubMed ID: 26873401
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Ishibashi O; Ushijima T; Takizawa T; Tajiri T
Int J Oncol; 2009 Mar; 34(3):767-75. PubMed ID: 19212681
[TBL] [Abstract][Full Text] [Related]
15. Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients.
Ahmad F; Badwe A; Verma G; Bhatia S; Das BR
Med Oncol; 2016 Jul; 33(7):74. PubMed ID: 27282497
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutation and gain of copy number of PIK3CA in human breast cancer.
Wu G; Xing M; Mambo E; Huang X; Liu J; Guo Z; Chatterjee A; Goldenberg D; Gollin SM; Sukumar S; Trink B; Sidransky D
Breast Cancer Res; 2005; 7(5):R609-16. PubMed ID: 16168105
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations in head and neck squamous cell carcinoma.
Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
[TBL] [Abstract][Full Text] [Related]
18. High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations.
Maeng CH; Lee J; van Hummelen P; Park SH; Palescandolo E; Jang J; Park HY; Kang SY; MacConaill L; Kim KM; Shim YM
PLoS One; 2012; 7(8):e41655. PubMed ID: 22870241
[TBL] [Abstract][Full Text] [Related]
19. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo.
Zhang H; Chen D; Ringler J; Chen W; Cui QC; Ethier SP; Dou QP; Wu G
Cancer Res; 2010 May; 70(10):3996-4004. PubMed ID: 20424113
[TBL] [Abstract][Full Text] [Related]
20. PI3K Overexpression and PIK3CA Mutations Are Associated with Age, Tumor Staging, and Other Clinical Characteristics in Chinese Patients with Esophageal Squamous Cell Carcinoma.
Lin JW; Li X; Qiu ML; Luo RG; Lin JB; Liu B
Genet Test Mol Biomarkers; 2017 Apr; 21(4):236-241. PubMed ID: 28384037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
